Literature DB >> 2849198

Straight ileoanal anastomosis with preserved anal mucosa for ulcerative colitis and familial polyposis.

R Emblem1, A Bergan, S Larsen.   

Abstract

Thirty-two patients were treated with colectomy, mucosal proctectomy, and straight ileoanal anastomosis. Mucosal dissection was performed from the abdominal side, and an anal mucosal brim of 1-2 cm was preserved. Diverting ileostomy was not used, and four patients developed anastomotic leak with pelvic sepsis. Three patients had take-down of the anastomosis for reasons related to the operative method. The remaining patients are all completely continent day and night and have a median stool frequency of 6/24 h 1 year after the operation. The frequency was significantly higher in patients with ulcerative colitis (UC) than in patients with familial polyposis (FP). No dysplasia, ulceration, or stricture formation was found in the preserved mucosa in the UC patients. Regrowth of polyps in the mucosal brim occurred in 10 of 13 FP patients, with atypia in 1. The FP patients had more late complications attributed to extracolonic manifestations of the FP disease.

Entities:  

Mesh:

Year:  1988        PMID: 2849198     DOI: 10.3109/00365528809090146

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  Functional outcome of stapled ileal pouch-anal canal anastomosis versus handsewn pouch-anal anastomosis.

Authors:  N Saigusa; T Kurahashi; T Nakamura; H Sugimura; S Baba; H Konno; S Nakamura
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

2.  Stapled ileoanal anastomosis for ulcerative colitis and familial polyposis without a temporary diverting ileostomy.

Authors:  H J Sugerman; H H Newsome; G Decosta; A M Zfass
Journal:  Ann Surg       Date:  1991-06       Impact factor: 12.969

3.  Radiological study of changes in the pelvis in women following proctocolectomy.

Authors:  M Asztély; S Palmblad; M Wikland; L Hultén
Journal:  Int J Colorectal Dis       Date:  1991-05       Impact factor: 2.571

Review 4.  Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited.

Authors:  Alex Kartheuser; Pierre Stangherlin; Dimitri Brandt; Christophe Remue; Christine Sempoux
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

5.  Randomized prospective trial comparing ileal pouch-anal anastomosis performed by excising the anal mucosa to ileal pouch-anal anastomosis performed by preserving the anal mucosa.

Authors:  W T Reilly; J H Pemberton; B G Wolff; S Nivatvongs; R M Devine; W J Litchy; P B McIntyre
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

6.  Cumulative risk of developing polyps or malignancy at the ileal pouch-anal anastomosis in patients with familial adenomatous polyposis.

Authors:  P van Duijvendijk; H F Vasen; L Bertario; S Bülow; J H Kuijpers; W R Schouten; J G Guillem; C W Taat; J F Slors
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

7.  Ileal pouch-anal anastomosis: comparison of results in familial adenomatous polyposis and chronic ulcerative colitis.

Authors:  R R Dozois; K A Kelly; D R Welling; H Gordon; R W Beart; B G Wolff; J H Pemberton; D M Ilstrup
Journal:  Ann Surg       Date:  1989-09       Impact factor: 12.969

Review 8.  Incidence and Risk Factors of Cancer in the Anal Transitional Zone and Ileal Pouch following Surgery for Ulcerative Colitis and Familial Adenomatous Polyposis.

Authors:  Guillaume Le Cosquer; Etienne Buscail; Cyrielle Gilletta; Céline Deraison; Jean-Pierre Duffas; Barbara Bournet; Géraud Tuyeras; Nathalie Vergnolle; Louis Buscail
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

9.  Advantages of total proctocolectomy with straight ileoanal anastomosis plus pedicled omental transposition for familial adenomatous polyposis: a preliminary study.

Authors:  Tianci Qin; Jiankun Liao; Haiquan Qin; Linghou Meng; Wentao Wang; Zigao Huang; Jungang Liu; Xianwei Mo
Journal:  World J Surg Oncol       Date:  2022-01-22       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.